Symbol: |
CECR1
|
Description: |
cat eye syndrome chromosome region, candidate 1 [Source:HGNC Symbol;Acc:1839]
|
Location: |
Chr22:17660194-17739125[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:301
Gene |
Compound |
Gen_sig |
Exp_pattern |
CECR1 |
NSC 175296 |
0.005 |
Down |
CECR1 |
1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- |
0.012 |
Down |
CECR1 |
Chrysanthin |
0.01 |
Down |
CECR1 |
Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester |
0.01 |
Down |
CECR1 |
2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- |
0.042 |
Down |
CECR1 |
NSC 26112 |
0.001 |
Down |
CECR1 |
6-Benzylthioinosine |
0.006 |
Down |
CECR1 |
NANAOMYCIN |
0.015 |
Down |
CECR1 |
2,2',5,5'-TETRAHYDROXY-4,4'-DIMETHYLBIPHENYL |
0.017 |
Down |
CECR1 |
GEL-I-195-1 |
0.031 |
Down |
CECR1 |
NSC 292596 |
0.042 |
Down |
CECR1 |
NSC 294153 |
0.042 |
Down |
CECR1 |
NSC 294526 |
0.008 |
Down |
CECR1 |
3-Phenacyliden-5-brom-2-indolinon |
0.01 |
Down |
CECR1 |
Cycloalkannin |
0.007 |
Down |
Expression pattern: Sensitivity / Resistance
Total:21 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:52
Total:4 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:8
Gene |
Gen_transcript |
miRNA |
miR_location |
CECR1 |
ENST00000262607 |
hsa-mir-198 |
Chr3:120114550-120114571[-] |
CECR1 |
ENST00000330232 |
hsa-mir-198 |
Chr3:120114550-120114571[-] |
CECR1 |
ENST00000262607 |
hsa-mir-339-3p |
Chr7:1062591-1062613[-] |
CECR1 |
ENST00000262607 |
hsa-mir-363-3p |
ChrX:133303412-133303433[-] |
CECR1 |
ENST00000330232 |
hsa-mir-363-3p |
ChrX:133303412-133303433[-] |
CECR1 |
ENST00000262607 |
hsa-mir-483-5p |
Chr11:2155411-2155432[-] |
CECR1 |
ENST00000262607 |
hsa-mir-499a-5p |
Chr20:33578211-33578231[+] |
CECR1 |
ENST00000262607 |
hsa-mir-649 |
Chr22:21388480-21388501[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|